The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance

References

• OrdituraMGaliziaGSforzaVTreatment of gastric cancerWorld J Gastroenterol20142071635164924587643
   PubMed Web of Science ®Google Scholar
• RothADChemotherapy in gastric cancer: a never ending sagaAnn Oncol200314217517712562640
   PubMed Web of Science ®Google Scholar
• LiuLNingXSunLInvolvement of MGr1-Ag/37LRP in the vincristine-induced HIF-1 expression in gastric cancer cellsMol Cell Biochem20073031–215116017476462
   PubMed Web of Science ®Google Scholar
• ZhangXYashiroMQiuHNishiiTMatsuzakiTHirakawaKEstablishment and characterization of multidrug-resistant gastric cancer cell linesAnticancer Res201030391592120393015
   PubMed Web of Science ®Google Scholar
• ChungYMParkSParkJKKimYKangYYooYDEstablishment and characterization of 5-fluorouracil-resistant gastric cancer cellsCancer Lett200015919510110974411
   PubMed Web of Science ®Google Scholar
• QiuHYashiroMZhangXMiwaAHirakawaKA FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cellsCancer Lett20113071475221482024
   PubMed Web of Science ®Google Scholar
• DonaldsonKLGoolsbyGLKienerPAWahlAFActivation of p34cdc2 coincident with taxol-induced apoptosisCell Growth Differ1994510104110507848905
   PubMedGoogle Scholar
• GabizonAPriceDCHubertyJBresalierRSPapahadjopoulosDEffect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studiesCancer Res19905019637163781698120
   PubMed Web of Science ®Google Scholar
• WardMWHuberHJWeisováPDüssmannHNichollsDGPrehnJHMitochondrial and plasma membrane potential of cultured cerebellar neurons during glutamate-induced necrosis, apoptosis, and toleranceJ Neurosci200727318238824917670970
   PubMed Web of Science ®Google Scholar
• StoeltzingOMcCartyMFWeyJSRole of hypoxia-inducible factor 1α in gastric cancer cell growth, angiogenesis, and vessel maturationJ Natl Cancer Inst2004961294695615199114
   PubMedGoogle Scholar
• McMahonSGrondinFMcDonaldPPRichardDEDuboisCMHypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteinsJ Biol Chem200528086561656915611046
   PubMed Web of Science ®Google Scholar
• Muñoz-NájarUMNeurathKMVumbacaFClaffeyKPHypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activationOncogene200625162379239216369494
   PubMed Web of Science ®Google Scholar
• MontagutCTusquetsIFerrerBActivation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patientsEndocr Relat Cancer200613260761616728586
   PubMed Web of Science ®Google Scholar
• RiusJGumaMSchachtrupCNF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1 alphaNature2008453719680781118432192
   PubMed Web of Science ®Google Scholar
• LiuLNingXSunLHypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancerCancer Sci200899112112817953712
   PubMed Web of Science ®Google Scholar
• TaniguchiKSakaiMSugitoNPKM1 is involved in resistance to anti-cancer drugsBiochem Biophys Res Commun2016473117418027012213
   PubMed Web of Science ®Google Scholar
• OkazakiMFushidaSHaradaSThe angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancerCancer Lett20143551465325224569
   PubMed Web of Science ®Google Scholar
• DonaldsonKLGoolsbyGLWahlAFCytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycleInt J Cancer19945768478557911457
   PubMed Web of Science ®Google Scholar
• QuinteroMMackenzieNBrennanPAHypoxia-inducible factor 1 (HIF-1) in cancerEur J Surg Oncol200430546546815135470
   PubMed Web of Science ®Google Scholar
• RussellDLIanSAdrianLThe role of hypoxia-inducible factor-1 in three-dimensional tumor growth, apoptosis, and regulation by the insulin-signaling pathwayCancer Res200565104147415215899805
   PubMed Web of Science ®Google Scholar
• UmJHKangCDBaeJHAssociation of DNA-dependent protein kinase with hypoxia inducible factor-1 and its implication in resistance to anticancer drugs in hypoxic tumor cellsExp Mol Med200436323324215272235
   PubMed Web of Science ®Google Scholar
• SemenzaGLSignal transduction to hypoxia-inducible factor 1Biochem Pharmacol2002645–699399812213597
   PubMed Web of Science ®Google Scholar
• HaradaHInoueMItasakaSCancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vesselsNat Commun2012378322510688
   PubMed Web of Science ®Google Scholar
• KitajimaYMiyazakiKThe critical impact of HIF-1a on gastric cancer biologyCancers (Basel)201351152624216696
   PubMedGoogle Scholar
• ConnollyDTHeuvelmanDMNelsonRTumor vascular permeability factor stimulates endothelial cell growth and angiogenesisJ Clin Invest1989845147014782478587
   PubMed Web of Science ®Google Scholar
• LeungDWCachianesGKuangWJGoeddelDVFerraraNVascular endothelial growth factor is a secreted angiogenic mitogenScience19892464935130613092479986
   PubMed Web of Science ®Google Scholar
• TrédanOLacroix-TrikiMGuiuSAngiogenesis and tumor microenvironment: bevacizumab in the breast cancer modelTarget Oncol201510218919825185646
   PubMed Web of Science ®Google Scholar
• ChenWTHuangCJWuMTYangSFSuYCChaiCYHypoxia-inducible factor 1 alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumorJpn J Clin Oncol200535420721315845570
   PubMed Web of Science ®Google Scholar
• MizokamiKKakejiYOdaSClinicopathological significance of hypoxia-inducible factor 1 alpha overexpression in gastric carcinomasJ Surg Oncol200694214915416847924
   PubMed Web of Science ®Google Scholar
• FukudaRKellyBSemenzaGLVascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1Cancer Res20036392330233412727858
   PubMed Web of Science ®Google Scholar
• BargouRCWagenerCBommertKOverexpression of the death-promoting gene Bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID miceJ Clin Invest19969711265126598647960
   PubMed Web of Science ®Google Scholar
• CrawfordANahtaRTargeting Bcl-2 in herceptin-resistant breast cancer cell linesCurr Pharmacogenomics Person Med20119318419022162984
   PubMedGoogle Scholar
• ShajahanANDobbinZCHickmanFEDakshanamurthySClarkeRTyrosine phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c-Jun N-terminal kinase (JNK)J Biol Chem201228721176821769222433870
   PubMed Web of Science ®Google Scholar
• ZhaoQTanBBLiYFanLQYangPGTianYEnhancement of drug sensitivity by knockdown of HIF-1α in gastric carcinoma cellsOncol Res201623312913626931435
   PubMed Web of Science ®Google Scholar
• EndoKMaeharaYKusumotoTIchiyoshiYKuwanoMSugimachiKExpression of multidrug-resistance-associated protein (MRP) and chemo-sensitivity in human gastric cancerInt J Cancer19966833723778903480
   PubMed Web of Science ®Google Scholar
• FanKFanDChengLFLiCExpression of multidrug resistance-related markers in gastric cancerAnticancer Res2000206C4809481411205224
   PubMed Web of Science ®Google Scholar
• ZhaoYXiaoBChenBQiaoTFanDUpregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transductionChin Med J (Engl)20001131197798011776130
   PubMed Web of Science ®Google Scholar
• XuHWXuLHaoJHQinCYLiuHExpression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancerJ Int Med Res2010381344220233511
   PubMed Web of Science ®Google Scholar
• SparreboomAvan AsperenJMayerULimited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProc Natl Acad Sci U S A1997945203120359050899
   PubMed Web of Science ®Google Scholar
• ChenJDingZPengYHIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoproteinPLoS One201496e9888224901645
   PubMed Web of Science ®Google Scholar
• ChristofkHRVander HeidenMGWuNAsaraJMCantleyLCPyruvate kinase M2 is a phosphotyrosine-binding proteinNature2008452718418118618337815
   PubMed Web of Science ®Google Scholar
• Vander HeidenMGCantleyLCThompsonCBUnderstanding the Warburg effect: the metabolic requirements of cell proliferationScience200932459301029103319460998
   PubMed Web of Science ®Google Scholar
• ChenMZhangJManleyJLTurning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNACancer Res201070228977898020978194
   PubMed Web of Science ®Google Scholar
• YangWXiaYJiHNuclear PKM2 regulates β-catenin transactivation upon EGFR activationNature2011480737511812222056988
   PubMed Web of Science ®Google Scholar
• TamadaMSuematsuMSayaHPyruvate kinase M2: multiple faces for conferring benefits on cancer cellsClin Cancer Res201218205554556123071357
   PubMed Web of Science ®Google Scholar
• ChristofkHRVander HeidenMGHarrisMHThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature2008452718423023318337823
   PubMed Web of Science ®Google Scholar
• WolfDAIs reliance on mitochondrial respiration a “chink in the armor” of therapy-resistant cancer?Cancer Cell201426678879525490445
   PubMed Web of Science ®Google Scholar